نتایج جستجو برای: human papillomavirus 16 and 18 types

تعداد نتایج: 17180718  

Journal: :jundishapur journal of microbiology 0
somayeh jalilian student research committee, kermanshah university of medical sciences, kermanshah, ir iran babak izadi molecular pathology research center, emam reza hospital, kermanshah university of medical sciences, kermanshah, iran seyed hamid madani molecular pathology research center, emam reza hospital, kermanshah university of medical sciences, kermanshah, iran parviz mohajeri department of microbiology, school of medicine, kermanshah university of medical sciences, kermanshah, ir iran; microbiology department, faculty of medicine, kermanshah university of medical sciences, shirudi blvd., parastar blvd., postal code: 6714869914, kermanshah, ir iran. tel: +98-9123715418, fax: +98-8334271566

results human papillomavirus was found in 62.1% of the samples obtained from the patients. among the hr and lr types, hpv-6 was the major genotype 64.8%. type 16 and 18 were the most frequent hr-hpv types (presented in 26% of the patient), followed by type 50s (24.7%), 45, 30s, and 11 (1.8% from each). multiple hpv infections were presented in 40.7% of the positive genotyping specimens. backgro...

Journal: :The Indian journal of medical research 2009
Mausumi Bharadwaj Showket Hussain Vilas Nasare Bhudev C Das

Cervical cancer is the second-most common cancer in women worldwide causing most cancer related deaths in women in developing countries including India. The most predominant etiological factor for cervical cancer is persistent infection of certain high-risk types of human papillomaviruses (HR-HPVs), while low-risk types are associated with benign cervical lesions and genital warts. In India, th...

2014
Mark H Einstein Peter Takacs Archana Chatterjee Rhoda S Sperling Nahida Chakhtoura Mark M Blatter Jacob Lalezari Marie-Pierre David Lan Lin Frank Struyf Gary Dubin

The observer-blind, randomized, age-stratified, head-to-head study (NCT00423046) comparing immunogenicity and safety of HPV-16/18 and HPV-6/11/16/18 vaccines in healthy women aged 18-45 y was completed. Five y after vaccination, in subjects from the Month 60 according-to-protocol cohort (seronegative and DNA negative for HPV type analyzed at baseline), serum neutralizing antibody (nAb) response...

Journal: :Acta virologica 2013
N Nor Rashid R Yusof R J Watson

It has been shown that the E7 protein of the high-risk HPV-16 transforms cells in vitro and binds pRB, p107 and p130, so called pocket proteins associated in cells with DREAM proteins, while that of the low-risk HPV-6 does not transform cells and binds p130 but not pRB or p107. These facts may indicate that p130 is essential for the HPV life cycle. To gain further insight into the relationship ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید